New Trends in Cutaneous Melanoma Surgery

The main surgical treatment for melanoma consists in wide surgical excision of the primary lesion and the sentinel node but in recent times management of melanoma is rapidly evolving with the introduction of new systemic therapies, like BRAF inhibitors, MEK inhibitors and antibodies anti-PD-1 that s...

Descripción completa

Detalles Bibliográficos
Autores principales: Scala, Jacopo, Vojvodic, Aleksandra, Vojvodic, Petar, Vlaskovic-Jovicevic, Tatjana, Peric-Hajzler, Zorica, Matovic, Dusica, Dimitrijevic, Sanja, Vojvodic, Jovana, Sijan, Goran, Stepic, Nenad, Wollina, Uwe, Tirant, Michael, Thuong, Nguyen Van, Fioranelli, Massimo, Lotti, Torello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910799/
https://www.ncbi.nlm.nih.gov/pubmed/31850129
http://dx.doi.org/10.3889/oamjms.2019.828
Descripción
Sumario:The main surgical treatment for melanoma consists in wide surgical excision of the primary lesion and the sentinel node but in recent times management of melanoma is rapidly evolving with the introduction of new systemic therapies, like BRAF inhibitors, MEK inhibitors and antibodies anti-PD-1 that show good results in controlling even advanced stages of the disease. This review aims to present data for the optimal surgical management of patients with malignant melanoma.

Ejemplares similares